相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
Mohammad Luqman et al.
BLOOD (2008)
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
David Naor et al.
SEMINARS IN CANCER BIOLOGY (2008)
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study
Asher Chanan-Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
CL Law et al.
CANCER RESEARCH (2005)
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia
W Eisterer et al.
LEUKEMIA RESEARCH (2004)
Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: A systematic review and meta-analysis
Q Zhu et al.
LEUKEMIA & LYMPHOMA (2004)
Disruption of the IFN-γ cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis
M Zaki et al.
LEUKEMIA RESEARCH (2000)
Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma
K Sasaki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)